Antibody Information
General Information of This Antibody
| Antibody ID | ANTI0BCDNN |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | SAC 1 |
|||||
| Synonyms |
SAC 1
Click to Show/Hide
|
|||||
| Antigen Name | Tumor-associated calcium signal transducer 2 (TACSTD2) |
Antigen Info | ||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
38981219 ADC 12b [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.006 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung papillary adenocarcinoma | NCI-H441 cells | CVCL_1561 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.017 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.019 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.066 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Hypopharyngeal squamous cell carcinoma | FaDu cells | CVCL_1218 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.086 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Breast acantholytic squamous cell carcinoma | HCC-1806 cells | CVCL_1258 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | Calu-6 cells | CVCL_0236 | ||
38981219 ADC 10b [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.008 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung papillary adenocarcinoma | NCI-H441 cells | CVCL_1561 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.021 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.035 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.067 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Hypopharyngeal squamous cell carcinoma | FaDu cells | CVCL_1218 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.076 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Breast acantholytic squamous cell carcinoma | HCC-1806 cells | CVCL_1258 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | Calu-6 cells | CVCL_0236 | ||
GsADC 5d [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.009 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung papillary adenocarcinoma | NCI-H441 cells | CVCL_1561 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.064 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.078 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.183 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Hypopharyngeal squamous cell carcinoma | FaDu cells | CVCL_1218 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
3.184 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Breast acantholytic squamous cell carcinoma | HCC-1806 cells | CVCL_1258 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | Calu-6 cells | CVCL_0236 | ||
GsADC 3b [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.011 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung papillary adenocarcinoma | NCI-H441 cells | CVCL_1561 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.056 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.073 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.233 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Hypopharyngeal squamous cell carcinoma | FaDu cells | CVCL_1218 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
2.592 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Breast acantholytic squamous cell carcinoma | HCC-1806 cells | CVCL_1258 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | Calu-6 cells | CVCL_0236 | ||
38981219 ADC 12a [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.018 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung papillary adenocarcinoma | NCI-H441 cells | CVCL_1561 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.028 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.034 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.124 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Hypopharyngeal squamous cell carcinoma | FaDu cells | CVCL_1218 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.564 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Breast acantholytic squamous cell carcinoma | HCC-1806 cells | CVCL_1258 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | Calu-6 cells | CVCL_0236 | ||
38981219 ADC 10a [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.019 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung papillary adenocarcinoma | NCI-H441 cells | CVCL_1561 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.024 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Hypopharyngeal squamous cell carcinoma | FaDu cells | CVCL_1218 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.042 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.044 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.188 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Breast acantholytic squamous cell carcinoma | HCC-1806 cells | CVCL_1258 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | Calu-6 cells | CVCL_0236 | ||
KsADC 7a [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.04 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung papillary adenocarcinoma | NCI-H441 cells | CVCL_1561 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.062 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.068 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.456 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Hypopharyngeal squamous cell carcinoma | FaDu cells | CVCL_1218 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.787 nM
|
High TROP2 expression (TROP2 +++) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Breast acantholytic squamous cell carcinoma | HCC-1806 cells | CVCL_1258 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The Cell Counting Kit-8 (CCK-8) assay was performed to measure the in vitro efficiency of ADCs. TROP2-expression tumor cell lines (BXPC-3, HCI-441, Fadu, HCC1806, NCI-N87) and TROP2 negative tumor cell lines (Calu-6) were cultured in a 10 % FBS-containing RPMI 1640 medium and were planted into 96-well plates with 6000 cells per well. The plates were incubated overnight at 37 °C in a 5 % CO2 cell incubator. All ADCs were diluted 5-fold with RPMI 1640 medium from an initial concentration of 100 nmol/L, a total of nine concentration gradients. The ADC samples were added to three wells with every single concentration and the 96-well plates were cultured at 37 °C in a 5 % CO2 cell incubator for six days. Then CCK8 solution was added and incubated at 37 °C for 4 h. Optical density (OD) value was measured at 450 nm using a BioTek Epoch. IC50 values and the cell viability curve were calculated by GraphPad software.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | Calu-6 cells | CVCL_0236 | ||
References
